Literature DB >> 20020422

Robust statistical methods for analysis of biomarkers measured with batch/experiment-specific errors.

Qi Long1, W Dana Flanders, Veronika Fedirko, Roberd M Bostick.   

Abstract

In many biological studies, biomarkers are measured with errors. In addition, study samples are often divided and measured in separate batches, and data collected from different experiments are used in a single analysis. Generally speaking, the structure of the measurement error is unknown and is not easy to ascertain. While the conditions under which the measurements are taken vary from one batch/experiment to another, they are often held steady within each batch/experiment. Thus, the measurement error can be considered batch/experiment specific, that is, fixed within each batch/experiment, which results into a rank-preserving property within each batch/experiment. Under this condition, we study robust statistical methods for analyzing the association between an outcome variable and predictors measured with error, and evaluating the diagnostic or predictive accuracy of these biomarkers. Our methods require no assumptions on the structure and distribution of the measurement error, which are often unrealistic. Compared with existing methods that are predicated on normality and additive structure of measurement errors, our methods still yield valid inferences under departure from these assumptions. The proposed methods are easy to implement using off-shelf software. Simulation studies show that under various measurement error structures, the performance of the proposed methods is satisfactory even for a fairly small sample size, whereas existing methods under misspecified structures and a naive approach exhibited substantial bias. Our methods are illustrated using a biomarker validation case-control study for colorectal neoplasms. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020422      PMCID: PMC3177604          DOI: 10.1002/sim.3796

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

Review 1.  Laboratory issues: use of nutritional biomarkers.

Authors:  Heidi Michels Blanck; Barbara A Bowman; Gerald R Cooper; Gary L Myers; Dayton T Miller
Journal:  J Nutr       Date:  2003-03       Impact factor: 4.798

Review 2.  Design options for molecular epidemiology research within cohort studies.

Authors:  Andrew G Rundle; Paolo Vineis; Habibul Ahsan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-08       Impact factor: 4.254

3.  Dimension reduction and mixed-effects model for microarray meta-analysis of cancer.

Authors:  Tianwei Yu; Hui Ye; Zugen Chen; Barry L Ziober; Xiaofeng Zhou
Journal:  Front Biosci       Date:  2008-01-01

Review 4.  Analysis of clustered data in receiver operating characteristic studies.

Authors:  C A Beam
Journal:  Stat Methods Med Res       Date:  1998-12       Impact factor: 3.021

5.  Nonparametric analysis of clustered ROC curve data.

Authors:  N A Obuchowski
Journal:  Biometrics       Date:  1997-06       Impact factor: 2.571

6.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

7.  Specimen allocation in longitudinal biomarker studies: controlling subject-specific effects by design.

Authors:  Shelley S Tworoger; Yutaka Yasui; Lilly Chang; Frank Z Stanczyk; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-07       Impact factor: 4.254

8.  Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d.

Authors:  Yiting Wang; Eric J Jacobs; Marjorie L McCullough; Carmen Rodriguez; Michael J Thun; Eugenia E Calle; W Dana Flanders
Journal:  Am J Epidemiol       Date:  2009-04-30       Impact factor: 4.897

9.  TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma.

Authors:  Carrie R Daniel; Roberd M Bostick; William Dana Flanders; Qi Long; Veronika Fedirko; Eduard Sidelnikov; March E Seabrook
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Veronika Fedirko; Roberd M Bostick; W Dana Flanders; Qi Long; Aasma Shaukat; Robin E Rutherford; Carrie R Daniel; Vaunita Cohen; Chiranjeev Dash
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-03
View more
  5 in total

1.  The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunities.

Authors:  Lauren J Beesley; Maxwell Salvatore; Lars G Fritsche; Anita Pandit; Arvind Rao; Chad Brummett; Cristen J Willer; Lynda D Lisabeth; Bhramar Mukherjee
Journal:  Stat Med       Date:  2019-12-20       Impact factor: 2.373

2.  A conditional likelihood approach for regression analysis using biomarkers measured with batch-specific error.

Authors:  Ming Wang; W Dana Flanders; Roberd M Bostick; Qi Long
Journal:  Stat Med       Date:  2012-07-24       Impact factor: 2.373

3.  Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.

Authors:  Matthew T White; Leslie M Shaw; Sharon X Xie
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

4.  Modeling clinical outcome using multiple correlated functional biomarkers: A Bayesian approach.

Authors:  Qi Long; Xiaoxi Zhang; Yize Zhao; Brent A Johnson; Roberd M Bostick
Journal:  Stat Methods Med Res       Date:  2012-10-14       Impact factor: 3.021

5.  Adjustment for measurement error in evaluating diagnostic biomarkers by using an internal reliability sample.

Authors:  Matthew T White; Sharon X Xie
Journal:  Stat Med       Date:  2013-06-14       Impact factor: 2.373

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.